SCHEMBL28682801

SCHEMBL28682801

CSc1nccc(C2(OC(N)=O)CCOCC2)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR4 Q5NUL3 1/20 0.36
▸ KMT2A Q03164 2/20 0.34
▸ ALOX5 P09917 2/20 0.33
▸ PDE4B Q07343 4/20 0.32
▸ PDE4A P27815 2/20 0.32
▸ PDE4C Q08493 2/20 0.32
▸ PDE4D Q08499 2/20 0.32
▸ PDE11A Q9HCR9 2/20 0.32
▸ PIK3CA P42336 1/20 0.32
▸ PDE3B Q13370 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ LMNA P02545 2/20 0.31
▸ ALDH1A1 P00352 2/20 0.31
▸ GAA P10253 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ ALOX15 P16050 1/20 0.31
▸ HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lithium Ion SCHEMBL22749301 0.78 FFAR4 (0.35) FFAR4KMT2AALOX5PDE4BTP53
SCHEMBL22758556 0.77 FFAR4 (0.39) FFAR4KMT2AALOX5PDE4BPDE4A
SCHEMBL21392151 0.77 FFAR4 (0.37) FFAR4ALOX5PDE4BPDE4APDE4C
SCHEMBL22749305 0.76 LMNA (0.36) FFAR4KMT2ALMNAALDH1A1GAA
Lithium SCHEMBL30725900 0.76 FFAR4 (0.38) FFAR4KMT2AALOX5PDE4BPDE4A
SCHEMBL29142075 0.76 FFAR4 (0.38) FFAR4KMT2AALOX5PDE4BPDE4A
SCHEMBL21392085 0.76 FFAR4 (0.35) FFAR4KMT2AALOX5LMNAALDH1A1
Hydrochloric Acid SCHEMBL29368124 0.75 LMNA (0.35) FFAR4KMT2ALMNAALDH1A1GAA
Hydrochloric Acid SCHEMBL28701070 0.75 LMNA (0.35) FFAR4KMT2ALMNAALDH1A1GAA
SCHEMBL22762634 0.73 LMNA (0.36) FFAR4ALOX5TP53LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114008039-B Compounds as human CTPS1 inhibitors for the treatment of proliferative diseases 斯泰普制药股份公司 2024-01-16 — — CN disclosed
CN-114008039-A N- (5- (6-ethoxypyrazin-2-yl) pyridin-2-yl) -4- (2- (methylsulfonylamino) pyrimidin-4-yl) tetrahydro-2H-pyran-4-carboxamide derivatives and related compounds as human CTPS1 inhibitors for the treatment of proliferative diseases 斯泰普制药股份公司 2022-02-01 — — CN disclosed
Send feedback